SCHEMBL1680463

SCHEMBL1680463

Cc1cccc(Br)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30849792 1.00
SCHEMBL130382 0.80
SCHEMBL362461 0.80
SCHEMBL31435744 0.80 ALDH1A1 (0.50)
SCHEMBL10301570 0.76 KDM1A (0.39)
SCHEMBL30228414 0.76 KDM1A (0.39)
SCHEMBL686929 0.75
SCHEMBL29661770 0.75
SCHEMBL264714 0.72
SCHEMBL60953 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998623-B2 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2011-08-16 US claimed
US-20060078792-A1 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2006-04-13 US claimed
EP-4741396-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT Canon Kabushiki Kaisha (JP) 2026-05-13 EP disclosed
US-20260130110-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KK (JP) 2026-05-07 US disclosed
EP-4648853-A1 TARGETED DEGRADATION OF VAV1 Monte Rosa Therapeutics AG (CH) 2025-11-19 EP disclosed
US-12421191-B2 3-hydroxyoxindole derivatives as CRHR2 antagonist RAQUALIA PHARMA INC. (JP) 2025-09-23 US disclosed
US-12344597-B2 Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis IDORSIA PHARMACEUTICALS LTD (CH) 2025-07-01 US disclosed
WO-2025013558-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT キヤノン株式会社 2025-01-16 WO disclosed
EP-4217062-B1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-10-09 EP disclosed
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 US disclosed
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed
US-5457235-A Halogenated diphenyldiacetylene liquid crystals DISPLAYTECH, INC. (US) 1995-10-10 US disclosed
EP-0607344-A1 3,4-DIHYDRO-4-OXO-3-(PROP-2-ENYL)-1-PHTALAZINEACETIC ACIDS AND DERIVATIVES, PREPARATIONS THEREOF AND DRUGS CONTAINING SAME LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1994-07-27 EP disclosed
WO-1993007109-A1 3,4-DIHYDRO-4-OXO-3-(PROP-2-ENYL)-1-PHTALAZINEACETIC ACIDS AND DERIVATIVES, PREPARATIONS THEREOF AND DRUGS CONTAINING SAME LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1993-04-15 WO disclosed
EP-0008734-B1 PROCESS FOR THE PREPARATION OF 4-FLUOR-3-PHENOXYTOLUENE BAYER AG (DE) 1981-07-29 EP disclosed
US-4266082-A Preparation of 4-fluoro-3-phenoxy-toluene BAYER AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed
US-4231953-A Fluoro substituted aryl esters and thiolesters of amino acids ZOECON CORPORATION (US) 1980-11-04 US disclosed
US-4229368-A Esters and thiolesters of unsaturated acids ZOECON CORPORATION (US) 1980-10-21 US disclosed
US-4225533-A Fluorobenzyl esters of cyclopropanecarboxylic acids ZOECON CORPORATION (US) 1980-09-30 US disclosed
EP-0008734-A1 Process for the preparation of 4-fluor-3-phenoxytoluene BAYER AG (DE) 1980-03-19 EP disclosed